Evidence map›Paper›PMID 29451925›Full record

ArticlePloS one2018

The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis.

Monique Abimpaye, Catherine M Kirk, Hari S Iyer, Neil Gupta, Eric Remera, Placidie Mugwaneza, Michael R Law

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monique AbimpayeRwanda Biomedical Center, Kigali, Rwanda.
Catherine M KirkPartners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.ORCID 0000-0001-9103-2611
Hari S IyerPartners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Neil GuptaPartners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Eric RemeraRwanda Biomedical Center, Kigali, Rwanda.
Placidie MugwanezaRwanda Biomedical Center, Kigali, Rwanda.
Michael R LawThe University of British Columbia, Vancouver, British Columbia, Canada.

Funding

Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
NCI NIH HHS T32 CA009001
6 · The paper itself

Abstract

backgroundNearly a quarter of a million children have acquired HIV, prompting the implementation of new protocols-Option B and B+-for treating HIV+ pregnant women. While efficacy has been demonstrated in randomized trials, there is limited real-world evidence on the impact of these changes. Using longitudinal, routinely collected data we assessed the impact of the adoption of WHO Option B in Rwanda on mother to infant transmission.

methodsWe used interrupted time series analysis to evaluate the impact of Option B on mother-to-child HIV transmission in Rwanda. Our primary outcome was the proportion of HIV tests in infants with positive results at six weeks of age. We included data for 20 months before and 22 months after the 2010 policy change.

resultsOf the 15,830 HIV tests conducted during our study period, 392 tested positive. We found a significant decrease in both the level (-2.08 positive tests per 100 tests conducted, 95% CI: -2.71 to -1.45, p < 0.001) and trend (-0.11 positive tests per 100 tests conducted per month, 95% CI: -0.16 to -0.07, p < 0.001) of test positivity. This represents an estimated 297 fewer children born without HIV in the post-policy period or a 46% reduction in HIV transmission from mother to child.

conclusionsThe adoption of Option B in Rwanda contributed to an immediate decrease in the rate of HIV transmission from mother to child. This suggests other countries may benefit from adopting these WHO guidelines.

Indexed as

Anti-HIV AgentsFemaleHIV-1HIV InfectionsHumansInfantInfectious Disease Transmission, VerticalLongitudinal StudiesPregnancyPregnancy Complications, InfectiousPregnancy OutcomeRwandaAnti-HIV Agents

Identifiers

PMID29451925
PMCPMC5815596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.